» Articles » PMID: 2053791

Prevalence of Liver Disease in Cystic Fibrosis

Overview
Journal Arch Dis Child
Specialty Pediatrics
Date 1991 Jun 1
PMID 2053791
Citations 36
Authors
Affiliations
Soon will be listed here.
Abstract

To assess the prevalence, demography, and clinical features of liver disease among patients with cystic fibrosis the case notes of 524 patients of all ages who were attending the cystic fibrosis clinic were studied. Computer databases were used to establish the condition of the liver in a further 576 such patients. The overall prevalence of overt liver disease indicated by the presence of an enlarged liver or spleen (or both) was 4.2%. The age related prevalence rose to a peak in adolescence, and then fell in patients over 20 years old. The implied increase in mortality among those with liver disease was not explained by deaths from liver disease, which were rare. Male patients were significantly more affected than female, the ratio being 3:1 among adolescents. Increasing prevalence of liver disease in patients with cystic fibrosis is, therefore, not just a result of longevity.

Citing Articles

Cystic fibrosis liver disease in Newfoundland and Labrador: a prevalence study.

Squirell E, Lockyer J Can Liver J. 2022; 4(1):33-37.

PMID: 35991469 PMC: 9203160. DOI: 10.3138/canlivj-2020-0012.


National trends and outcomes of genetically inherited non-alcoholic chronic liver disease in the USA: estimates from the National Inpatient Sample (NIS) database.

Sieloff E, Rutledge B, Huffman C, Vos D, Melgar T Gastroenterol Rep (Oxf). 2021; 9(1):38-48.

PMID: 33747525 PMC: 7962742. DOI: 10.1093/gastro/goaa091.


Early pathogenesis of cystic fibrosis gallbladder disease in a porcine model.

Zarei K, Stroik M, Gansemer N, Thurman A, Ostedgaard L, Ernst S Lab Invest. 2020; 100(11):1388-1399.

PMID: 32719544 PMC: 7578062. DOI: 10.1038/s41374-020-0474-8.


The emerging burden of liver disease in cystic fibrosis patients: A UK nationwide study.

Toledano M, Mukherjee S, Howell J, Westaby D, Khan S, Bilton D PLoS One. 2019; 14(4):e0212779.

PMID: 30947265 PMC: 6448894. DOI: 10.1371/journal.pone.0212779.


Cystic Fibrosis Liver Disease: Outcomes and Risk Factors in a Large Cohort of French Patients.

Boelle P, Debray D, Guillot L, Clement A, Corvol H Hepatology. 2018; 69(4):1648-1656.

PMID: 30058245 PMC: 6519059. DOI: 10.1002/hep.30148.


References
1.
Isenberg J . Cystic fibrosis: its influence on the liver, biliary tree, and bile salt metabolism. Semin Liver Dis. 1982; 2(4):302-13. DOI: 10.1055/s-2008-1040717. View

2.
Webster R, Williams H . Hepatic cirrhosis associated with fibrocystic disease of the pancreas; clinical and pathological reports of five patients. Arch Dis Child. 1953; 28(141):343-50. PMC: 1988617. DOI: 10.1136/adc.28.141.343. View

3.
Becker M, Staab D, Leiss O, von Bergmann K . Biliary lipid composition in patients with cystic fibrosis. J Pediatr Gastroenterol Nutr. 1989; 8(3):308-12. DOI: 10.1097/00005176-198904000-00008. View

4.
Graham N, Manhire A, Stead R, Lees W, Hodson M, Batten J . Cystic fibrosis: ultrasonographic findings in the pancreas and hepatobiliary system correlated with clinical data and pathology. Clin Radiol. 1985; 36(2):199-203. DOI: 10.1016/s0009-9260(85)80120-3. View

5.
Kattwinkel J, Taussig L, Statland B, Verter J . The effects of age on alkaline phosphatase and other serologic liver function tests in normal subjects and patients with cystic fibrosis. J Pediatr. 1973; 82(2):234-42. DOI: 10.1016/s0022-3476(73)80160-x. View